Public Company News

Microsoft to acquire Activision Blizzard to bring the joy and community of gaming to everyone, across every device

Legendary games, immersive interactive entertainment and publishing expertise accelerate growth in Microsoft's Gaming business across mobile, PC, console and cloud.  REDMOND, Wash. and SANTA MONICA, Calif., Jan. 18, 2022 /PRNewswire/ -- With three billion people actively playing games today, ...

2022-01-18 21:46 1674

Bigtincan is a Gold Medalist in the 2022 SoftwareReviews Sales Enablement Data Quadrant Buyers Guide Report

Ranked #1 by Users for Vendor Capabilities and Product Features WALTHAM, Mass., Jan. 18, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), the global leader in sales enablement automation, today announced that it has been recognized as a gold medalist and leader in the 2022 Sales Enablement Data Quadra...

2022-01-18 21:08 858

CN Energy Signs Operation & Management Agreement; Enters Multi-Billion Dollar Pharmaceutical Excipients Market

LISHUI, China, Jan. 18, 2022 /PRNewswire/ -- CN Energy Group. Inc. (the "Company") today announced that its subsidiary Hangzhou Forasen Technology Co., Ltd. signed an operation and management ("O&M") agreement (the "Agreement") with HuaiNan JiaHe New Materials Co., Ltd. ("JiaHe") and JiaHe's acti...

2022-01-18 21:00 649

I-Mab Announces First Patient Dosed in China Phase 2 Combination Trial of Lemzoparlimab with Toripalimab in Patients with Advanced Solid Tumors

SHANGHAI and GAITHERSBURG, Md., Jan. 18, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed in itsChina phase ...

2022-01-18 21:00 616

Farmmi Builds on International Growth with Repeat Customer Order

LISHUI, China, Jan. 18, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier inChina, today announced the Company's subsidiary Zhejiang Farmmi Biotechnology Co., Ltd., won another follow-on product order. The latest order for dried Shiitak...

2022-01-18 21:00 1118

Akeso's AK117 (CD47 monoclonal antibody) in Combination with AK112 (PD-1/VEGF bi-specific antibody) to Initiate a Phase Ib/II Clinical Trial with or without Chemotherapy for the Treatment of Advanced Malignant Tumors

HONG KONG, Jan. 18, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) announces that Ligufalimab (CD47 monoclonal antibody, research and development code: AK117), the novel immuno-oncology drug independently developed by the Company, combined with Ivonescimab (PD-1/VEGF bi-specific antibody, research an...

2022-01-18 20:44 829

Sungrow Launches "1+X" Modular Inverter at World Future Energy Summit, 2022

ABU DHABI, UAE, Jan. 18, 2022 /PRNewswire/ -- Sungrow, the global leading inverter solution supplier for renewables, officially launches the brand-new central inverter -- "1+X" Modular Inverter at World Future Energy Summit, a high-profile international event for global sustainability and transit...

2022-01-18 20:34 757

Clarivate Patent Trend Report Shows Increasing Business Focus on Innovation Through Patent Portfolio Spend

Global organizations cite patent innovation as key to increasing competitive advantage amidst the pandemic LONDON, Jan. 18, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new re...

2022-01-18 20:09 775

Ascletis Announces Signing of Ritonavir Tablet Purchase Agreement with Phokam Pharmaceutical Import-Export Co., Ltd of Laos

HANGZHOU and SHAOXING, China, Jan. 18, 2022 /PRNewswire/ -- Ascletis Pharma Inc. ("Ascletis") (HKEX: 1672) today announces signing of the ritonavir tablet purchase agreement between Phokam Pharmaceutical Import-Export Co., Ltd (as buyer) ofLaos and Ascletis Pharmaceuticals Co., Ltd. (as seller), ...

2022-01-18 18:00 932

Pickle Crow Gold Project, Canada

KEY POINTS * Drilling of high-grade veins outside the Resource in the Shaft 1 and Shaft 3 areas continues to deliver significant intersections, including:  - 7.3m @ 33.3 g/t gold from 9.4m in AUDD0246 - 1.5m @ 35.2 g/t gold from 541.5m in AUDD0227 - 4.0m @ 11.0 g/t gold from 205.8m in AUDD024...

2022-01-18 17:38 587

CATL Launches Battery Swap Solution EVOGO Featuring Modular Battery Swapping

* CATL's subsidiary CAES has rolled out EVOGO, its innovative modular battery swap solution, which includes battery blocks, fast battery swap stations, and an app * EVOGO's features include high compatibility with vehicle models, need-based battery rental, and complementarity with fast chargi...

2022-01-18 17:24 889

Yum China Caters to Local Tastes with Regional Menu Items

SHANGHAI, Jan. 18, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) announced that its KFC brand is increasingly tapping into regional Chinese cuisines and adding traditional local dishes to its menu. In 2021, to support further market penetr...

2022-01-18 16:30 850

Onion Global Surpasses RMB100 Million in GMV During its 2022 New Year's Shopping Festival

GUANGZHOU, China, Jan. 18, 2022 /PRNewswire/ -- Onion Global Limited ("Onion Global", the "Group" or the "Company") (NYSE: OG), a next-generation lifestyle brand platform that incubates, markets, and distributes the world's fresh, fashionable, and future brands to young people inChina and across ...

2022-01-18 16:00 1516

Online Blockchain plc: The Red Village and Umbria Partner to Create a Seamless Gaming Experience

- Highly anticipated blockchain game integrates Narni bridge widget into  platform LONDON, Jan. 18, 2022 /PRNewswire/ -- Umbria Network is providing The Red Village community with a fast, cheap and easy way to bridge ETH to the Polygon network (WETH) via its new bridge widget.

2022-01-18 15:00 914

InnoCare and Keymed Jointly Announce Dosing of First Patient in Clinical Trial of CD20xCD3 Bispecific Antibody CM355

BEIJING, Jan. 18, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the first patient inChina has been dosed in clinical trial of CM355, a CD20xCD3 bispecific antibody developed by a joint venture between the two companies, for th...

2022-01-18 14:51 660

Oliver Wyman Digital Launches Edge, a Plug-and-Play Banking and Insurance Platform

SINGAPORE and KUALA LUMPUR, Malaysia and HONG KONG, Jan. 18, 2022 /PRNewswire/ -- Oliver Wyman Digital today announced the launch of Edge, a digital platform with Banking-as-a-Service (BaaS) and Insurance-as-a-Service (IaaS) solutions to help incumbent banks and digital challengers accelerate the...

2022-01-18 14:07 1592

BEST Inc. Receives Notice Regarding NYSE Continued Listing Standards

HANGZHOU, China, Jan. 18, 2022 /PRNewswire/ -- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"), a leading integrated smart supply chain solutions and logistics services provider inChina, today announced that it received a letter from the New York Stock Exchange (the "NYSE"), datedJanuary 5, 2022...

2022-01-18 14:00 708

Oliver Wyman Digital Launches Edge, a Plug-and-Play Banking and Insurance Platform

It only takes 6-9 months to build a digital bank or insurance solution with Edge. SINGAPORE and KUALA LUMPUR, Malaysia and HONG KONG, Jan. 18, 2022 /PRNewswire/ -- Oliver Wyman Digital today announced the launch of Edge, a digital platform with Banking-as-a-Service (BaaS) and Insurance-as-a-Serv...

2022-01-18 13:40 1585

WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility

* WuXi Biologics completes the first GMP inspection in 2022, demonstrating the company's premier quality system is in full compliance with global regulatory requirements. WUXI, China, Jan. 17, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access ...

2022-01-18 10:50 876

Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules

SHANGHAI, Jan. 17, 2022 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter), a subsidiary of Abbisko Cayman Limited (Stock Code: 2256.HK), today announced that it has entered into a worldwide collaboration and exclusive licensing agreement (the "Agreement") with Eli ...

2022-01-18 10:41 821
1234567 ... 1214